Sample size for main trial
pain
SECONDARY
Our final secondary objective was to obtain statistical parameters to inform the main trial sample size calculation. We calculated that a fully powered parallel-group superiority trial would require 122 participants (i.e.: 61 per group) using a previously-determined minimal clinically important difference in the efficacy outcome measure (MOXFQ pain subscale) of 12 points [